IR-News

AUSSENDER



Marinomed Biotech AG
Ansprechpartner: Elisabeth Schön
Tel.: +43226290300
E-Mail: elisabeth.schoen@marinomed.com

FRüHERE MELDUNGEN

25.01.2021 - 14:15 | Marinomed Biotech AG
25.01.2021 - 13:52 | Marinomed Biotech AG
17.12.2020 - 13:00 | Marinomed Biotech AG
17.12.2020 - 13:00 | Marinomed Biotech AG
17.12.2020 - 13:00 | Marinomed Biotech AG

WEITERE IR-NEWS

12.04.2021 - 19:40 | Biofrontera AG
12.04.2021 - 18:24 | Wolftank-Adisa Holding AG
12.04.2021 - 15:30 | Singulus Technologies Aktiengesellschaft
pta20210126023
Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Marinomed Biotech AG: Correction of a Release according to art. 135 section 2 BörseG from 25.01.2021


Korneuburg (pta023/26.01.2021/12:19) - Release of Announcement according to art. 135 section 2 BörseG

Notification of Major Holdings

1. Issuer:
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: Acropora Beteiligungs GmbH
City and country of registered office: Vienna, Austria

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
Mohammed Al Sheikh
Abdulmohsen Al Sheikh

5. Date on which threshold was crossed or reached
21.01.2021

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached 13.86 0.00 13.86 1,474,731
Position of previous notification 16.59 0.00 16.59

7. Notified details of the resulting situation

7.a. Voting rights attached to shares

ISIN code absolute direct (Sec 130 BörseG 2018) absolute indirect (Sec 133 BörseG 2018) in % direct (Sec 130 BörseG 2018) in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 0 204,410 0.00 13.86
Total: 204,410 13.86

7.b.1. Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument Expiration Date Exercise Period Voting Rights Absolute Voting Rights in %
Total:

7.b.2 Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

Type of instrument Expiration Date Exercise Period Physical /Cash Settlement Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity.

No. Name Directly controlled by No. Shares held directly (%) Financial/other instruments held directly (%) Total of both (%)
1 Abdulmohsen Al Sheikh
2 Mohammed Al Sheikh
3 Acropora Beteiligungs GmbH 1,2 13.86 13.86

9. In case of proxy voting

Date of general meeting: N/A

10. Additional Information
The participation notification is based on the fact that the threshold is not reached after the sale of 38,450 shares.

(end)
emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
contact person: Elisabeth Schön
phone: +43226290300
e-mail: elisabeth.schoen@marinomed.com
website: www.marinomed.com
stock exchanges: official trade in Vienna
ISIN(s): ATMARINOMED6 (share)
|
|
98.141 Abonnenten
|
188.750 Meldungen
|
77.307 Pressefotos

BUSINESS

12.04.2021 - 13:13 | faircheck Schadenservice GmbH
12.04.2021 - 11:30 | pressetext.redaktion
12.04.2021 - 10:00 | Heemann Vermögensverwaltung AG
12.04.2021 - 09:45 | ITCS
12.04.2021 - 06:10 | pressetext.redaktion
Top